Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 7;8(1):00630-2021.
doi: 10.1183/23120541.00630-2021. eCollection 2022 Jan.

The prevalence and burden of interstitial lung diseases in the USA

Niranjan Jeganathan  1 , Matheni Sathananthan  2
Affiliations

The prevalence and burden of interstitial lung diseases in the USA

Niranjan Jeganathan et al. ERJ Open Res. .

Abstract

Interstitial lung diseases (ILDs) are a significant contributor to disability and deaths in the USA. The prevalence and deaths from ILDs have increased but when adjusted for age, have been stable since 2010. https://bit.ly/3IDlZrg.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: N. Jeganathan has nothing to disclose. Conflict of interest: M. Sathananthan has nothing to disclose.

References

    1. Cottin V, Hirani NA, Hotchkin DL, et al. . Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases. Eur Respir Rev 2018; 27: 180076. doi:10.1183/16000617.0076-2018 - DOI - PMC - PubMed
    1. Cottin V, Wollin L, Fischer A, et al. . Fibrosing interstitial lung diseases: knowns and unknowns. Eur Respir Rev 2019; 28: 180100. doi:10.1183/16000617.0100-2018 - DOI - PMC - PubMed
    1. Frank AL, Kreuter M, Schwarzkopf L. Economic burden of incident interstitial lung disease (ILD) and the impact of comorbidity on costs of care. Respir Med 2019; 152: 25–31. doi:10.1016/j.rmed.2019.04.009 - DOI - PubMed
    1. Fan Y, Bender SDConoscenti CS,et al. . Hospital-based resource use and costs among patients with idiopathic pulmonary fibrosis enrolled in the idiopathic pulmonary fibrosis prospective outcomes (IPF-PRO) registry. Chest 2020; 157: 1522–1530. doi:10.1016/j.chest.2019.12.041 - DOI - PubMed
    1. GBD Chronic Respiratory Disease Collaborators . Prevalence and attributable health burden of chronic respiratory diseases, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med 2020; 8: 585–596. doi:10.1016/S2213-2600(20)30105-3 - DOI - PMC - PubMed

LinkOut - more resources